Cytokinetics Inc (CYTK) — Net Asset Quality Index
Cytokinetics Inc (CYTK) has a Net Asset Quality Index of -64.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.27 Billion minus total liabilities of $2.10 Billion yields net assets of $-826.57 Million. A higher index indicates a stronger, lower-leverage balance sheet. See CYTK cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cytokinetics Inc Net Asset Quality Index Over Time (2000–2025)
This chart shows how Cytokinetics Inc's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at -64.9%, representing net assets of $-826.57 Million against total assets of $1.27 Billion USD. Explore how efficiently does Cytokinetics Inc generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Cytokinetics Inc (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Cytokinetics Inc from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CYTK market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -46.3% | $-659.62 Million | $1.42 Billion | $2.08 Billion | ▼ -36.6 pp |
| 2024 | -9.7% | $-135.37 Million | $1.40 Billion | $1.54 Billion | ▲ +37.2 pp |
| 2023 | -46.9% | $-386.32 Million | $824.32 Million | $1.21 Billion | ▼ -36.2 pp |
| 2022 | -10.6% | $-107.90 Million | $1.01 Billion | $1.12 Billion | ▼ -39.6 pp |
| 2021 | 29.0% | $243.86 Million | $841.32 Million | $597.46 Million | ▲ +7.7 pp |
| 2020 | 21.2% | $113.38 Million | $533.80 Million | $420.42 Million | ▲ +25.0 pp |
| 2019 | -3.8% | $-10.94 Million | $289.81 Million | $300.75 Million | ▼ -16.1 pp |
| 2018 | 12.3% | $25.93 Million | $211.18 Million | $185.24 Million | ▼ -25.0 pp |
| 2017 | 37.3% | $109.84 Million | $294.81 Million | $184.97 Million | ▼ -18.2 pp |
| 2016 | 55.5% | $94.36 Million | $170.14 Million | $75.78 Million | ▼ -4.1 pp |
| 2015 | 59.5% | $68.59 Million | $115.24 Million | $46.65 Million | ▼ -9.7 pp |
| 2014 | 69.2% | $92.06 Million | $132.97 Million | $40.90 Million | ▲ +3.8 pp |
| 2013 | 65.4% | $54.44 Million | $83.19 Million | $28.75 Million | ▼ -26.7 pp |
| 2012 | 92.1% | $71.44 Million | $77.55 Million | $6.11 Million | ▲ +0.8 pp |
| 2011 | 91.3% | $48.18 Million | $52.77 Million | $4.59 Million | ▲ +0.9 pp |
| 2010 | 90.4% | $70.52 Million | $77.99 Million | $7.48 Million | ▲ +7.7 pp |
| 2009 | 82.7% | $101.43 Million | $122.60 Million | $21.17 Million | ▲ +25.8 pp |
| 2008 | 56.9% | $49.77 Million | $87.45 Million | $37.69 Million | ▼ -7.4 pp |
| 2007 | 64.3% | $99.92 Million | $155.37 Million | $55.45 Million | ▲ +1.6 pp |
| 2006 | 62.7% | $106.31 Million | $169.52 Million | $63.20 Million | ▼ -17.7 pp |
| 2005 | 80.4% | $73.56 Million | $91.46 Million | $17.90 Million | ▼ -3.5 pp |
| 2004 | 84.0% | $107.56 Million | $128.10 Million | $20.55 Million | ▲ +230.3 pp |
| 2003 | -146.4% | $-92.03 Million | $62.87 Million | $154.90 Million | ▼ -38.5 pp |
| 2002 | -107.9% | $-60.59 Million | $56.17 Million | $116.76 Million | ▼ -60.6 pp |
| 2001 | -47.3% | $-37.35 Million | $79.02 Million | $116.37 Million | ▼ -11.5 pp |
| 2000 | -35.7% | $-21.82 Million | $61.04 Million | $82.86 Million | — |